Health & Medicine Giuseppe Recchia, Convegno Mitocon 2015

1. Bisogni players Why? RD Priorities Discovery Clinical Trials competitivenesspharmaceutical Technologies Rare Diseases Scenario    2. Bisogni players Why? RD Priorities…

Science Introduction to Discovery Partnerships with Academia (DPAc)

1. Introduction to Discovery Partnerships with Academia (DPAc) Alternative Discovery & Development GlaxoSmithKline R&D A new model for partnering with academia to…

Documents New_DPAc_external_presentation_Mar15

1. Introduction to Discovery Partnerships with Academia (DPAc) Alternative Discovery & Development GlaxoSmithKline R&D A new model for partnering with academia to…